Aeolus to Present at the 10th Annual BIO Investor Forum
October 24, 2011 10:02 ET
|
Aeolus Pharmaceuticals
MISSION VIEJO, CA--(Marketwire - Oct 24, 2011) - Aeolus Pharmaceuticals, Inc. (OTCQB: AOLS) (PINKSHEETS: AOLS), a biotechnology company leveraging significant funding from the U.S. Department of...
Aeolus Pharmaceuticals Announces NIH Counteract Grant Award to Develop AEOL 10150 as a Treatment Against Nerve Agent Exposure
October 24, 2011 07:01 ET
|
Aeolus Pharmaceuticals
MISSION VIEJO, CA--(Marketwire - Oct 24, 2011) - Aeolus Pharmaceuticals, Inc. (OTCQB: AOLS) (PINKSHEETS: AOLS), a biotechnology company leveraging significant funding from the U.S. Department of...
Aeolus Pharmaceuticals Announces $12.7 Million NIH Counteract Grant Award to Continue Development of AEOL 10150 as a Treatment Against Chlorine and Sulfur Mustard Gas Exposure
October 10, 2011 11:55 ET
|
Aeolus Pharmaceuticals
MISSION VIEJO, CA--(Marketwire - Oct 10, 2011) - Aeolus Pharmaceuticals, Inc. (OTCQB: AOLS) (PINKSHEETS: AOLS), a biotechnology company that is leveraging up to $140M of government funding in...
Roth Capital Initiates Equity Research Analyst Coverage on Aeolus
October 05, 2011 11:28 ET
|
Aeolus Pharmaceuticals
MISSION VIEJO, CA--(Marketwire - Oct 5, 2011) - Aeolus Pharmaceuticals, Inc. (OTCQB: AOLS) (PINKSHEETS: AOLS), a biotechnology company that is leveraging up to $140M of government funding in...
Joint Commission Alert: Use Diagnostic Radiation Carefully
August 24, 2011 11:53 ET
|
The Joint Commission
OAKBROOK TERRACE, IL--(Marketwire - Aug 24, 2011) - While diagnostic radiation tests can help save lives, a new Joint Commission Sentinel Event Alert warns that health care organizations must seek...
New Heart Scan May Speed up Diagnosis With Less Radiation
August 23, 2011 16:00 ET
|
American Heart Association
Study Highlights:
The next generation of computerized tomography (CT) scans appears faster and more accurate than current scans for measuring blood supply to the heart muscle.
A small trial...
Targeted Intraoperative Radiotherapy (TARGIT) Clinical Trial Outcomes Demonstrate the Potential for Single-Dose Radiation Therapy to Become the New Standard of Care in Breast Cancer Therapy
June 05, 2010 08:01 ET
|
TARGIT
CHICAGO, IL--(Marketwire - June 5, 2010) - TARGIT-A, the largest randomized clinical trial conducted in the field of intra-operative radiotherapy (IORT) for the treatment of breast cancer, has...
TARGIT Intraoperative Radiation Therapy: Long Awaited Results of the TARGeted Intraoperative radioTherapy (TARGIT) Trial to Be Announced at ASCO 2010
May 26, 2010 11:40 ET
|
TARGIT
LONDON--(Marketwire - May 26, 2010) - Patients with breast cancer await with interest the outcomes of a study exploring the role of targeted intra-operative radiotherapy using the...
Clinical Data for Carl Zeiss Meditec's INTRABEAM Targeted Intraoperative Radiotherapy System for Breast Cancer to Be Presented at ASCO 2010
May 26, 2010 11:40 ET
|
Carl Zeiss Meditec
JENA, GERMANY and DUBLIN, CA--(Marketwire - May 26, 2010) - Carl Zeiss Meditec announced that the TARGIT-A (TARGeted Intra-operative radiation Therapy) multicenter clinical trial that used the...